Cargando…
Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment
Glycosphingolipid expression differs between human breast cancer stem cells (CSC) and cancer non-stem cells (non-CSC). We performed studies of viability, type of cell death, cancer stem cell percent and glycosphingolipid expression on CSC and non-CSC after treatment of MDA-MB-231 and MDA-MB-453 trip...
Autores principales: | Marijan, Sandra, Markotić, Anita, Mastelić, Angela, Režić-Mužinić, Nikolina, Pilkington, Lisa Ivy, Reynisson, Johannes, Čulić, Vedrana Čikeš |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368022/ https://www.ncbi.nlm.nih.gov/pubmed/32680999 http://dx.doi.org/10.1038/s41598-020-68516-y |
Ejemplares similares
-
Author Correction: Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment
por: Marijan, Sandra, et al.
Publicado: (2021) -
Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound
por: Mastelić, Angela, et al.
Publicado: (2017) -
Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s(+) Breast Cancer Cells
por: Marijan, Sandra, et al.
Publicado: (2021) -
Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism
por: Pervan, Matij, et al.
Publicado: (2022) -
Hyperbaric environment up-regulates CD15s expression on leukocytes, down-regulates CD77 expression on renal cells and up-regulates CD34 expression on pulmonary and cardiac cells in rat
por: Đevenica, Danka, et al.
Publicado: (2016)